| Time |
Opening
Remark |
| 09:00-09:10 |
Vice President Chen Chien-Jen
Republic of China (Taiwan)
|
|
Deputy
Minister Ho Chi-Kung
Ministry of Health and Welfare |
 |
| I. Enterovirus
epidemics and control |
| |
Topic |
Speaker
|
| 09:10-09:40 |
Keynote speech I:
Enterovirus A71 research in Taiwan: review and implications
|
Dr.
Tzou-Yien Lin
NHRI, Taiwan |
|
| 09:40-10:10 |
Keynote speech II:
Enterovirus epidemiology in the United States: surveillance overview
and recent EV-D68 and EV-A71 activity |
Dr.
John Watson
CDC, USA |
 |
| 10:10-10:40 |
Enterovirus surveillance,
preparedness, and response in Taiwan |
Dr. Yi-Chun Lo
CDC, Taiwan |
 |
| II. Pathogenesis
and virulence of EV-A71 |
| 11:00-11:20 |
Immunopathogenesis
of severe EV-A71 infections |
Dr. Ching-Chuan Liu
NCKUH, Taiwan |
 |
| 11:20-11:35 |
Pathogenesis
of acute heart failure in patients with enterovirus 71 rhombencephalitis |
Dr. Yun-Ching Fu
CMUCH, Taiwan |
 |
| 11:35-11:50 |
Management of EV-A71 patients with cardiopulmonary
failure |
Dr. Shao-Hsuan Hsia
CGMH, Taiwan |
 |
| 11:50-12:10 |
Genetic evolution of EV-A71: impacts on
antigenicity and virulence
|
Dr. Jen-Ren Wang
NCKU, Taiwan |
|
| III.
Neurological and immune response to EV-A71 |
| 13:30-13:50 |
Acute neurological complications
of EV-A71 infection in Taiwan |
Dr. Chao-Ching Huang
TMU, Taiwan |
 |
| 13:50-14:10 |
EV-A71 seroepidemiology
study in Taiwan and long-term neurological, and psychiatric outcome
after CNS
involvement |
Dr. Luan-Yin Chang
NTUH, Taiwan |
 |
| 14:10-14:20 |
Humoral immune response to
acute EV-A71 infection |
Dr. Kuan-Ying Arther Huang
CGMH, Taiwan |
 |
| 14:20-14:30 |
TLR defect in children with
severe EV-A71 infection |
Dr. Cheng-Lung Ku
CGU, Taiwan |
 |
| IV. EV-A71
vaccine development |
| 14:30-14:45 |
EV-A71 vaccine development
in Taiwan |
Dr. Chia-Chyi Liu
NHRI, Taiwan |
 |
| 14:45-14:55 |
Clinical development of the
first bioreactor-generated pediatric Enterovirus 71 vaccine |
Dr. Chin-Fan Yang
Enimmune, Taiwan
|
 |
| 14:55-15:05 |
EV-A71 vaccine clinical
trial in Taiwan |
Dr. Kathy Tai
Medigen, Taiwan
|
 |
| 15:05-15:15 |
Mucosal viral-vector
vaccines in study and prevention of enterovirus infection |
Dr. Yen-Hung Chow
NHRI, Taiwan |
 |
| 15:15-15:25 |
Anit-enterovirus A71 inhibitors: current status
and future perspectives
|
Dr. Jim-Tong Horng
CGU, Taiwan |
 |
| V. Enteroviruses
in Asia-Pacific regions |
| 15:45-16:00 |
Human enterovirus 71
disease in Malaysia |
Dr. Mong How Ooi
Hospital Umum Sarawak, Malaysia |
 |
| 16:00-16:15 |
Current situation of
enterovirus infection in Thailand |
Dr. Yong Poovorawan
Chulalongkorn
University, Thailand |
 |
| 16:15-16:30 |
Molecular epidemiology of human enterovirus 71 in
Cambodia |
Dr. Veasna Duong
Institut Pasteur de Camgodge, Cambodia |
 |
| 16:30-16:45 |
Establishment of Asia-Pacific
Network for Enterovirus Surveillance (APNES) |
Dr. Ming-Shi Lee
NHRI, Taiwan |
 |
| 16:45-17:00 |
Global burden and spread of enteroviruses:
opportunities for international collaborations |
Dr. Margarita Pons-Salort
Imperial College Lodon, England |
 |
